ECBK:NASDAQECB Bancorp, Inc. Analysis
Data as of 2026-06-13 - not real-time
$19.32
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
ECB Bancorp (ECBK) is trading at $19.32, comfortably above its 20‑day ($18.39), 50‑day ($18.24) and 200‑day ($17.20) simple moving averages, and the RSI sits at 64, indicating solid upward momentum without being overbought. The MACD histogram is positive and the MACD signal is bullish, while volume has been increasing, all pointing to a short‑term bullish trend. The stock is near a technical resistance around $19.70 and has a support level near $17.52, leaving modest upside potential toward the DCF‑derived fair value of $20.85.
Fundamentally, the company posted a 44% year‑over‑year revenue surge to $34.8 M, with an operating margin of 45% and a profit margin of 27.6%, underscoring strong profitability. Valuation metrics are attractive: a PE of 16.7 is in line with the industry average of 16.8, the price‑to‑book ratio is below 1 (0.96), and the DCF suggests the stock is undervalued. Low beta (0.42) and a 30‑day volatility of ~23% indicate limited systematic risk, though regional‑bank regulatory exposure remains a consideration.
Fundamentally, the company posted a 44% year‑over‑year revenue surge to $34.8 M, with an operating margin of 45% and a profit margin of 27.6%, underscoring strong profitability. Valuation metrics are attractive: a PE of 16.7 is in line with the industry average of 16.8, the price‑to‑book ratio is below 1 (0.96), and the DCF suggests the stock is undervalued. Low beta (0.42) and a 30‑day volatility of ~23% indicate limited systematic risk, though regional‑bank regulatory exposure remains a consideration.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price trading just below technical resistance at $19.70
- bullish MACD and RSI indicating upward momentum
- increasing volume supporting short‑term demand
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- 44% YoY revenue growth driving earnings expansion
- high operating margin (45%) delivering strong profitability
- DCF fair value of $20.85 suggests upside from current price
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- price‑to‑book below 1 provides a margin of safety
- low beta (0.42) reduces exposure to market swings
- potential recovery and consolidation in the regional‑bank sector
Key Metrics & Analysis
Financial Health
Revenue Growth44.40%
Profit Margin27.59%
P/E Ratio16.7
ROE5.57%
ROA0.62%
P/B Ratio1.0
Op. Cash Flow$12.7M
Industry P/E16.8
Technical Analysis
TrendBullish
RSI64.3
Support$17.52
Resistance$19.70
MA 20$18.39
MA 50$18.24
MA 200$17.20
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair Value$20.85
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.42
Volatility22.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.